{
  "DOI": "10.1038/sj.ejhg.5201542",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/sj.ejhg.5201542",
  "alternative-id": [
    "BF5201542"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Vahteristo",
      "given": "Pia",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Syrjäkoski",
      "given": "Kirsi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Heikkinen",
      "given": "Tuomas",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Eerola",
      "given": "Hannaleena",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Aittomäki",
      "given": "Kristiina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "von Smitten",
      "given": "Karl",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Holli",
      "given": "Kaija",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Blomqvist",
      "given": "Carl",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kallioniemi",
      "given": "Olli-Pekka",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Nevanlinna",
      "given": "Heli",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2005,
        12,
        7
      ]
    ],
    "date-time": "2005-12-07T11:44:28Z",
    "timestamp": 1133955868000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T01:35:24Z",
    "timestamp": 1684373724000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        16
      ]
    ],
    "date-time": "2023-10-16T21:57:58Z",
    "timestamp": 1697493478032
  },
  "is-referenced-by-count": 35,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2005,
        12,
        7
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2006,
          2
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2005,
            12,
            7
          ]
        ],
        "date-time": "2005-12-07T00:00:00Z",
        "timestamp": 1133913600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/5201542.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/5201542",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/5201542.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "167-172",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2005,
        12,
        7
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2005,
        12,
        7
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2006,
        2
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1086/301749",
      "author": "D Ford",
      "doi-asserted-by": "publisher",
      "first-page": "676",
      "journal-title": "Am J Hum Genet",
      "key": "BF5201542_CR1",
      "unstructured": "Ford D, Easton DF, Stratton M et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62: 676–689.",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1054/bjoc.2000.1626",
      "author": "P Vahteristo",
      "doi-asserted-by": "publisher",
      "first-page": "704",
      "journal-title": "Br J Cancer",
      "key": "BF5201542_CR2",
      "unstructured": "Vahteristo P, Eerola H, Tamminen A, Blomqvist C, Nevanlinna H : A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast–ovarian cancer families. Br J Cancer 2001; 84: 704–708.",
      "volume": "84",
      "year": "2001"
    },
    {
      "DOI": "10.1038/ng879",
      "author": "H Meijers-Heijboer",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "journal-title": "Nat Genet",
      "key": "BF5201542_CR3",
      "unstructured": "Meijers-Heijboer H, van den Ouweland A, Klijn J et al: Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002; 31: 55–59.",
      "volume": "31",
      "year": "2002"
    },
    {
      "DOI": "10.1086/341943",
      "author": "P Vahteristo",
      "doi-asserted-by": "publisher",
      "first-page": "432",
      "journal-title": "Am J Hum Genet",
      "key": "BF5201542_CR4",
      "unstructured": "Vahteristo P, Bartkova J, Eerola H et al: A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 2002; 71: 432–438.",
      "volume": "71",
      "year": "2002"
    },
    {
      "DOI": "10.1002/ijc.20299",
      "author": "O Kilpivaara",
      "doi-asserted-by": "publisher",
      "first-page": "543",
      "journal-title": "Int J Cancer",
      "key": "BF5201542_CR5",
      "unstructured": "Kilpivaara O, Vahteristo P, Falck J et al: CHEK2 variant I157T may be associated with increased breast cancer risk. Int J Cancer 2004; 111: 543–547.",
      "volume": "111",
      "year": "2004"
    },
    {
      "DOI": "10.1002/gepi.1014",
      "author": "AC Antoniou",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Genet Epidemiol",
      "key": "BF5201542_CR6",
      "unstructured": "Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D : Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 2001; 21: 1–18.",
      "volume": "21",
      "year": "2001"
    },
    {
      "DOI": "10.1038/sj.bjc.6600008",
      "author": "AC Antoniou",
      "doi-asserted-by": "publisher",
      "first-page": "76",
      "journal-title": "Br J Cancer",
      "key": "BF5201542_CR7",
      "unstructured": "Antoniou AC, Pharoah PD, McMullan G et al: A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 2002; 86: 76–83.",
      "volume": "86",
      "year": "2002"
    },
    {
      "DOI": "10.1038/ng1296-430",
      "author": "LC Wu",
      "doi-asserted-by": "publisher",
      "first-page": "430",
      "journal-title": "Nat Genet",
      "key": "BF5201542_CR8",
      "unstructured": "Wu LC, Wang ZW, Tsan JT et al: Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 1996; 14: 430–440.",
      "volume": "14",
      "year": "1996"
    },
    {
      "DOI": "10.1093/hmg/7.2.195",
      "author": "TH Thai",
      "doi-asserted-by": "publisher",
      "first-page": "195",
      "journal-title": "Hum Mol Genet",
      "key": "BF5201542_CR9",
      "unstructured": "Thai TH, Du F, Tsan JT et al: Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. Hum Mol Genet 1998; 7: 195–202.",
      "volume": "7",
      "year": "1998"
    },
    {
      "DOI": "10.1016/S0092-8674(01)00270-7",
      "author": "FE Kleiman",
      "doi-asserted-by": "publisher",
      "first-page": "743",
      "journal-title": "Cell",
      "key": "BF5201542_CR10",
      "unstructured": "Kleiman FE, Manley JL : The BARD1–CstF-50 interaction links mRNA 3’ end formation to DNA damage and tumor suppression. Cell 2001; 104: 743–753.",
      "volume": "104",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S1097-2765(01)00406-3",
      "author": "I Irminger-Finger",
      "doi-asserted-by": "publisher",
      "first-page": "1255",
      "journal-title": "Mol Cell",
      "key": "BF5201542_CR11",
      "unstructured": "Irminger-Finger I, Leung WC, Li J et al: Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis. Mol Cell 2001; 8: 1255–1266.",
      "volume": "8",
      "year": "2001"
    },
    {
      "DOI": "10.1002/1097-0215(20001001)88:1\u003c28::AID-IJC5\u003e3.0.CO;2-4",
      "author": "K Yoshikawa",
      "doi-asserted-by": "publisher",
      "first-page": "28",
      "journal-title": "Int J Cancer",
      "key": "BF5201542_CR12",
      "unstructured": "Yoshikawa K, Ogawa T, Baer R et al: Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas. Int J Cancer 2000; 88: 28–36.",
      "volume": "88",
      "year": "2000"
    },
    {
      "DOI": "10.1136/jmg.2004.020669",
      "author": "SM Karppinen",
      "doi-asserted-by": "publisher",
      "first-page": "e114",
      "journal-title": "J Med Genet",
      "key": "BF5201542_CR13",
      "unstructured": "Karppinen SM, Heikkinen K, Rapakko K, Winqvist R : Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer. J Med Genet 2004; 41: e114.",
      "volume": "41",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S0304-3835(03)00387-2",
      "author": "M Ishitobi",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Cancer Lett",
      "key": "BF5201542_CR14",
      "unstructured": "Ishitobi M, Miyoshi Y, Hasegawa S et al: Mutational analysis of BARD1 in familial breast cancer patients in Japan. Cancer Lett 2003; 200: 1–7.",
      "volume": "200",
      "year": "2003"
    },
    {
      "DOI": "10.1093/hmg/6.13.2309",
      "author": "P Vehmanen",
      "doi-asserted-by": "publisher",
      "first-page": "2309",
      "journal-title": "Hum Mol Genet",
      "key": "BF5201542_CR15",
      "unstructured": "Vehmanen P, Friedman LS, Eerola H et al: Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum Mol Genet 1997; 6: 2309–2315.",
      "volume": "6",
      "year": "1997"
    },
    {
      "DOI": "10.1016/S0959-8049(00)00093-9",
      "author": "H Eerola",
      "doi-asserted-by": "publisher",
      "first-page": "1143",
      "journal-title": "Eur J Cancer",
      "key": "BF5201542_CR16",
      "unstructured": "Eerola H, Blomqvist C, Pukkala E, Pyrhonen S, Nevanlinna H : Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 2000; 36: 1143–1148.",
      "volume": "36",
      "year": "2000"
    },
    {
      "DOI": "10.1093/jnci/92.18.1529",
      "author": "K Syrjakoski",
      "doi-asserted-by": "publisher",
      "first-page": "1529",
      "journal-title": "J Natl Cancer Inst",
      "key": "BF5201542_CR17",
      "unstructured": "Syrjakoski K, Vahteristo P, Eerola H et al: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. J Natl Cancer Inst 2000; 92: 1529–1531.",
      "volume": "92",
      "year": "2000"
    },
    {
      "DOI": "10.1002/ijc.20638",
      "author": "O Kilpivaara",
      "doi-asserted-by": "publisher",
      "first-page": "575",
      "journal-title": "Int J Cancer",
      "key": "BF5201542_CR18",
      "unstructured": "Kilpivaara O, Bartkova J, Eerola H et al: Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients. Int J Cancer 2005; 113: 575–580.",
      "volume": "113",
      "year": "2005"
    },
    {
      "author": "AC Syvanen",
      "first-page": "46",
      "journal-title": "Am J Hum Genet",
      "key": "BF5201542_CR19",
      "unstructured": "Syvanen AC, Sajantila A, Lukka M : Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. Am J Hum Genet 1993; 52: 46–59.",
      "volume": "52",
      "year": "1993"
    },
    {
      "DOI": "10.1007/s00439-002-0902-4",
      "author": "RS Houlston",
      "doi-asserted-by": "crossref",
      "first-page": "434",
      "journal-title": "Hum Genet",
      "key": "BF5201542_CR20",
      "unstructured": "Houlston RS, Peto J : The future of association studies of common cancers. Hum Genet 2003; 112: 434–435.",
      "volume": "112",
      "year": "2003"
    },
    {
      "DOI": "10.1038/sj.onc.1202717",
      "author": "R Dechend",
      "doi-asserted-by": "publisher",
      "first-page": "3316",
      "journal-title": "Oncogene",
      "key": "BF5201542_CR21",
      "unstructured": "Dechend R, Hirano F, Lehmann K et al: The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators. Oncogene 1999; 18: 3316–3323.",
      "volume": "18",
      "year": "1999"
    },
    {
      "DOI": "10.1038/sj.onc.1207427",
      "author": "CE Jefford",
      "doi-asserted-by": "publisher",
      "first-page": "3509",
      "journal-title": "Oncogene",
      "key": "BF5201542_CR22",
      "unstructured": "Jefford CE, Feki A, Harb J, Krause KH, Irminger-Finger I : Nuclear–cytoplasmic translocation of BARD1 is linked to its apoptotic activity. Oncogene 2004; 23: 3509–3520.",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1002/gcc.1223",
      "author": "C Ghimenti",
      "doi-asserted-by": "publisher",
      "first-page": "235",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "BF5201542_CR23",
      "unstructured": "Ghimenti C, Sensi E, Presciuttini S et al: Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations. Genes Chromosomes Cancer 2002; 33: 235–242.",
      "volume": "33",
      "year": "2002"
    }
  ],
  "reference-count": 23,
  "references-count": 23,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/5201542"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition"
  ],
  "type": "journal-article",
  "volume": "14"
}